Four-story pharmaceutical facility will be built from demolition material from existing site buildings
Engineer Mott MacDonald has won a contract to design a £45m pharmaceutical facility in Cheshire.
The firm has been appointed by AstraZeneca UK to the four-storey research and development scheme at Alderley Park.
The project will house several research labs, including a pre-clinical imaging facility, and will be built out of demolition material from existing buildings on the site.
Chris Oakes, Mott MacDonald’s project manager, said: “This is an important facility for AstraZeneca, and the design brief was necessarily complex to accommodate the pharmaceutical capabilities.
He added: “The site is located in the centre of a very busy operational research and development facility, so from a construction viewpoint minimal disruption to existing operations and services will be a key requirement of the project.”